Packaging Advice

What really causes pharmaceutical packaging failures in transit (and how to prevent them)

6 mins

Pharmaceutical products rarely fail in the lab; they fail in transit. A shipment can leave the manufacturing facility fully compliant and properly validated, only to arrive damaged, exposed to temperature excursions, or with compromised integrity because the packaging wasn’t designed for real distribution conditions.

Modern pharmaceutical supply chains are complex and unpredictable. Multiple handling points, re-palletising, vibration, compression, temperature fluctuations, and humidity all create risks that many packaging systems are not fully engineered to withstand. Even compliant pharmaceutical packaging can still fail when exposed to the realities of logistics.

That’s because pharmaceutical packaging failures are often system failures, not simple material failures. Packaging is too often designed in isolation rather than around the full transport journey.

At Swiftpak, we design pharmaceutical packaging solutions for real-world distribution environments, helping to reduce transit damage, minimise temperature excursions, and improve supply chain reliability. In this article, we explore the most common causes of pharmaceutical packaging failures in transit and how smarter packaging design can help prevent them.

The hidden reality of pharmaceutical transit environments

Pharmaceutical supply chains are often described as “controlled” environments, but the reality of transit is far less predictable. Most pharmaceutical shipments pass through multiple stages before reaching their destination, including warehouses, distribution hubs, courier networks, and final-mile delivery routes. Every transfer point introduces additional handling and additional risk.

Throughout the journey, products are repeatedly moved, re-palletised, reloaded, and exposed to changing environmental conditions. Vibration during transport, compression from stacking, temperature fluctuations, and humidity exposure can all place significant stress on both the packaging system and the product itself.

While packaging may perform well under static testing conditions, real-world logistics environments are dynamic and inconsistent. Without pharmaceutical packaging that is engineered specifically for these transit conditions, even compliant shipments can become vulnerable to damage, temperature changes, and compromised product integrity.

The most common causes of pharmaceutical packaging failure in transit

Pharmaceutical packaging failures rarely happen because of a single issue. In most cases, they result from a combination of environmental stress, handling pressures, and packaging systems that are not fully aligned with real transport conditions.

Some of the most common causes include:

  • Temperature excursion breakdowns: Inadequate thermal protection, poor insulation performance, or extended transit delays can expose temperature-sensitive products to conditions outside their validated range.
  • Mechanical damage: Repeated handling, stacking pressure, vibration, and impacts during transport can lead to crushed packaging, damaged products, or compromised seals.
  • Poor void management: Excess internal movement within the pack increases the risk of product collision, breakage, and reduced thermal stability during transit.
  • Packaging system mismatch: Packaging that performs well in controlled testing may not be suitable for the actual distribution route, shipment duration, or transport method being used.
  • Handling and human factors: Incorrect packaging processes, inconsistent loading methods, and courier handling errors can all undermine otherwise compliant packaging systems.

Many of these failures occur despite packaging meeting baseline compliance standards, highlighting the gap between laboratory validation and real-world logistics performance.

Why compliant packaging still fails

Meeting compliance standards does not always guarantee successful real-world performance. Pharmaceutical packaging may pass laboratory validation and still fail during distribution because actual transit conditions are far more variable than controlled testing environments.

Several factors contribute to this gap between compliance and performance:

  • Compliance does not equal real-world protection: Packaging can meet regulatory requirements while still being vulnerable to damage, temperature changes, or handling stress during transport.
  • Testing conditions are often limited: Many validation processes cannot fully replicate the complexity of real logistics networks, including repeated handling, delays, or fluctuating environmental conditions.
  • Routes, seasons, and carriers vary significantly: A packaging system that performs well on one route or during one season may underperform in different climates, transit durations, or courier networks.
  • Packaging is frequently validated in isolation: Individual materials or components may be tested separately, rather than assessing how the full packaging system performs throughout the entire distribution journey.

This is why pharmaceutical packaging failures are often operational rather than purely technical. Effective packaging design must account for the realities of distribution, not just the minimum standards required for compliance.

How to prevent pharma packaging failures in transit

Reducing transit failures requires more than simply selecting compliant packaging materials. Effective pharmaceutical packaging must be engineered around the realities of the distribution journey, with protection built into every stage of handling and transport.

Key ways to reduce transit risk include:

  • Engineer packaging around the distribution journey: Packaging should be designed based on actual transport routes, shipment durations, handling conditions, and environmental exposure.
  • Improve thermal protection design: Temperature-sensitive products require validated thermal systems that can withstand delays, seasonal changes, and fluctuating transit conditions without compromising product stability.
  • Control internal movement: Protective inserts, cushioning, and effective void management help prevent products from shifting during transit, reducing the risk of impact damage and thermal inconsistency.
  • Strengthen outer packaging integrity: Durable outer packaging helps protect against compression, vibration, stacking pressure, and repeated handling throughout complex supply chains.
  • Standardise packaging processes: Consistent packing methods, clear handling procedures, and operational standardisation help minimise human error and improve shipment reliability.

Even small improvements in packaging design and process control can significantly reduce damage rates, temperature changes, and costly product losses across pharmaceutical supply chains.

How Swiftpak reduces transit failure risk

At Swiftpak, pharmaceutical packaging is designed around the realities of modern distribution networks, helping businesses reduce damage, minimise temperature excursions, and improve supply chain reliability.

Bespoke engineered pharmaceutical packaging solutions

We develop tailored packaging systems designed specifically for pharmaceutical products, shipment profiles, and distribution environments, rather than relying on standard off-the-shelf solutions.

Temperature-controlled packaging solutions

Swiftpak provides temperature-controlled packaging designed to help maintain product stability for chilled and sensitive pharmaceutical products throughout transit.

Protective inserts and void fill solutions

From stepped foam inserts to paper void-fill systems, our protective packaging solutions help reduce internal movement and protect sensitive products during handling and transportation.

ISTA-tested packaging design

Swiftpak’s bespoke packaging solutions can be laboratory tested to ISTA standards, helping ensure packaging performs effectively under transit conditions.

Designed to reduce transit risk and variability

By engineering packaging around real transport challenges, Swiftpak helps businesses improve packaging consistency, reduce transit damage, and better protect sensitive pharmaceutical products throughout the supply chain.

pharmaceutical packaging whitepaper

Reducing pharmaceutical packaging failures through smarter design and validation

Most pharmaceutical packaging failures are system failures rather than simple material failures. Modern transit environments are far more demanding and unpredictable than many packaging systems are designed to handle, with constant handling, environmental changes, and logistical variability increasing the risk of damage and temperature changes.

Reducing these failures requires packaging that is engineered around the real distribution journey, not just designed to meet compliance standards. Small improvements to thermal protection, void management, packaging strength, and process consistency can make a significant difference to product protection and supply chain reliability.

Swiftpak helps pharmaceutical businesses develop engineered packaging solutions designed for real-world transit conditions, helping reduce risk, improve consistency, and protect sensitive products throughout the supply chain.